XLON
CVSG
Market cap1.06bUSD
Oct 09, Last price
1,173.00GBP
1D
2.45%
1Q
-5.10%
Jan 2017
6.35%
IPO
402.36%
Name
CVS Group PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CVS Group plc, established in 1999 and based in Diss, United Kingdom, is a comprehensive animal care provider with diverse operations. The company's activities are broadly categorized into four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It manages a large network of animal veterinary clinics and complementary diagnostic laboratories. CVS Group also offers pet cremation services, including the disposal of clinical waste for veterinary practices, and provides pet burial grounds. Furthermore, the company operates Animed Direct, an e-commerce platform that functions as an online pharmacy and retail outlet, distributing both prescription and over-the-counter animal medications, premium pet nutrition, and various other pet care essentials. Additional services include the supply of veterinary instrumentation and referral services. Currently, CVS Group's portfolio comprises 506 veterinary practices, 3 laboratories, 7 crematoria, and a dedicated online pharmacy.
Related entities
Subsidiaries
CVS (UK) LIMITED
Key people
David Wilton
Independent Non-Executive Chairman of the Board · since 2024
Richard Fairman
Chief Executive Officer, Executive Director · since 2019
Claire Slater
Chief Operating Officer · since 2025
Robin Alfonso
Chief Financial Officer, Executive Director · since 2021
Paul Higgs
Chief Veterinary Officer, Executive Director · since 2024
Scott Morrison
Company Secretary · since 2023
Richard Gray
Non-Executive Independent Director · since 2020
Deborah Kemp
Senior Non-Executive Independent Director · since 2024
Joanne Shaw
Non-Executive Independent Director · since 2023
Headquarters & legal address
CVS HOUSE
OWEN ROAD
DISS, NFK IP22 4ER
GB
OWEN ROAD
DISS, NFK IP22 4ER
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||